Tempusai

TEM: From losing money to making it NASDAQ:TEM Tempus AI builds the largest platform of clinical and genomic data, combining diagnostics, artificial intelligence, and drug development. The company partners with AstraZeneca, Bristol Myers Squibb, BioNTech, and other major pharmaceutical companies. The stock trades on NASDAQ. Fundamentals The Q2 2026 report confirmed a fundamental business turnaround. Revenue grew 22 percent year-over-year to $382.5 million, beating analyst consensus. Diagnostics contributed $289.3 million (+2

by TotoshkaTrades

TEM is back in Accumulation.Take a look at Tempus AI (TEM) through the lens of structure. Yes - the same Tempus AI name that drew major attention after Nancy Pelosi’s disclosed position. Price has moved back into the TrendGo Accumulate zone again - and that makes this chart interesting. Why? Because we have already seen what this type of setup can lead to on the same chart. In the previous Accumulation phase, TEM entered the zone, stabilized, and then expanded aggressively higher. At the time, the setup did not look

by StructuraMarkets

TEM Tempus AI Options Ahead of Earnings Analyzing the options chain and the chart patterns of TEM Tempus AI prior to the earnings report this week, I would consider purchasing the $30 strike price Calls with an expiration date of 2026-3-6, for a premium of approximately $3.20. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.

Tempus AI — Is This Where Time Turns Bullish Again?Fundamental View Tempus AI (NASDAQ: TEMP) continues to attract attention with major partnerships in the AI and biotech space — including collaborations with AstraZeneca, Illumina, and Boehringer Ingelheim. These deals strengthen its role in using AI for diagnostics and drug development, giving it strong long-term growth potential. However, as a newly listed and high-growth company, short-term volatility remains likely. Technical View Price has made a sharp retracement into the golden OTE zon

by INSIDER_INTEL

$TEM - New ATH's Inbound! 50% Upside NASDAQ:TEM - New ATH's Inbound! 🚀 Bull Flag Breakout = $84.17 🎯 74.20 Cup&Handle Breakout = $110 🎯 WCB forming 📈

TEM Weekly Options Play – 2025-06-10 🧾 TEM Weekly Options Play – 2025-06-10 Bias: Moderately Bullish Timeframe: 5 trading days Catalysts: Positive fundamentals, stable macro, bullish option flow Trade Type: Single-leg CALL option 🧠 Model Summary Table Model Direction Strike Entry Price Target Stop Loss Confidence Grok Bullish 63.00C $2.45 $3.68 $1.72 65% Claude Bullish 65.00C $1.70 $3.00 $0.85 72% Llama Bullish 63.00C $2.30 $2.76 $2.07 70% Gemini Bullish 68.00C $1.05 $2.00 $0.50 65% DeepSeek Bullish 63.00C $2.40 $4.80 $1.20 70% ✅

by quantsignals

$TEM - GET READY! 30%+ Upside NASDAQ:TEM - GET READY! ✅ Inverse H&S Breakout ✅ Falling Wedge Breakout 🎯 Targets: $77.43 & $90.63 Before August!

$TEM has a great symmetry Great Fib channel on tem. It respected the lowest trendline now we wait on the rest!

by CapitalCompass333

$TEM - MASSIVE Opportunity for this Nancy Pelosi Darling!NASDAQ:TEM - Does History Repeat?! 🤯 Same Draw Down could lead to Same Upside! My target is $100 🎯 Crazy High Risk/ High Reward if we repeat the same timeframe we get in less than a MONTH!!! (Wouldn't count on it, crazy if happens though) Not Financial Advice

Tempus Ai is not done yet! 70% Upside NASDAQ:TEM Called the DIP, Now calling the RIP! $115 Inbound! 🎯 - Volume Shelf - Retesting previous highs to flip into support - WCB Creating support and bottom - H5 is GREEN with BUY SIGNAL - Down on market weakness Not financial advice

Is Nancy Pelosi about to RUG PULL $TEM - Tempus Ai?!NASDAQ:TEM : DIP BUYING OPP INCOMING? DIP BUY BOX: $70-$80 We are very extended after breaking out of previous resistance and into ATHs! We are slamming into the Red barrier, which typically brings much-needed pullbacks. This would build out our WCB and allow us to continue higher while staying within those confines. Also, need to flip previous resistance into support before we can continue higher in a healthy manner. We could just keep flying higher, but at that point, we would have a mass

Tempus AI: Analyzing Tempus AI, Inc. (NASDAQ: TEM): Is It a Buy Industry Position and Growth Potential · Market Trends: The AI in healthcare market is projected to grow at a compound annual growth rate (CAGR) of approximately 45.1% from 2023 to 2030, driven by demand for personalized medicine and advancements in AI technology. · Competitive Landscape: Tempus AI competes with companies like IBM Watson Health and Google Health. However, Tempus's data-driven approach and partnerships with academic and research institutions provide differentiation.

by TheTrade_Academ

Tempus AI (TEM) Investment Analysis Company Overview: Tempus AI NASDAQ:TEM specializes in AI-driven healthcare solutions, focusing on improving patient outcomes and accelerating medical research. By leveraging extensive datasets and advanced analytics, Tempus provides innovative precision medicine solutions, solidifying its position in the growing AI healthcare sector. Key Growth Drivers: Strategic Acquisition of Ambry Genetics: Tempus AI's acquisition of Ambry Genetics significantly enhances its capabilities in genetic testi

by Richtv_official